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We compared the effects of methyl levulinate (MAL)/photodynamic therapy (PDT) and 
adapalene, evaluated singly, versus combination therapy on HaCaT keratinocytes. Our 
aim was to determine whether the additive/synergistic outcomes of combination treatment 
were such that doses of each component could be reduced without affecting treatment 
efficacy. The analysis of data from specific PDT/adapalene combinations results 
indicating effects ranging from additive to clearly synergistic. We first evaluated the 
effects on cell viability, cell cycle and protein expression profiles of each individual treatment, 
then we tried to understand the reasons and the mechanisms whereby cells under 
combined treatment move more efficiently to death. Although we observed therapeutic 
strengthening by increasing either drug doses or light fluences, reinforcement was particularly 
marked in combinations in which PDT was predominant. Thus, if PDT is 
appropriately tuned, the dose of the drug can be reduced without compromising the therapeutic 
response. As both photodynamic therapy and adapalene have been and are therapeutic 
approaches to treat different dermatological pathologies such as acne, actinic 
keratosis etc., our data suggest that the adapalene-PDT combination may have important 
spin-off in clinical dermatology as a strategy to tackle this nasty condition. 
